Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 15 11 2020
accepted: 29 12 2020
entrez: 25 3 2021
pubmed: 26 3 2021
medline: 24 6 2021
Statut: epublish

Résumé

Multiple proteinases are present in the synovial fluid (SF) of an arthritic joint. We aimed to identify inflammatory cell populations present in psoriatic arthritis (PsA) SF compared to osteoarthritis (OA) and rheumatoid arthritis (RA), identify their proteinase-activated receptor 2 (PAR2) signaling function and characterize potentially active SF serine proteinases that may be PAR2 activators. Flow cytometry was used to characterize SF cells from PsA, RA, OA patients; PsA SF cells were further characterized by single cell 3'-RNA-sequencing. Active serine proteinases were identified through cleavage of fluorogenic trypsin- and chymotrypsin-like substrates, activity-based probe analysis and proteomics. Fluo-4 AM was used to monitor intracellular calcium cell signaling. Cytokine expression was evaluated using a multiplex Luminex panel. PsA SF cells were dominated by monocytes/macrophages, which consisted of three populations representing classical, non-classical and intermediate cells. The classical monocytes/macrophages were reduced in PsA compared to OA/RA, whilst the intermediate population was increased. PAR2 was elevated in OA vs. PsA/RA SF monocytes/macrophages, particularly in the intermediate population. PAR2 expression and signaling in primary PsA monocytes/macrophages significantly impacted the production of monocyte chemoattractant protein-1 (MCP-1). Trypsin-like serine proteinase activity was elevated in PsA and RA SF compared to OA, while chymotrypsin-like activity was elevated in RA compared to PsA. Tryptase-6 was identified as an active serine proteinase in SF that could trigger calcium signaling partially PAR2 and its activating proteinases, including tryptase-6, can be important mediators of inflammation in PsA. Components within this proteinase-receptor axis may represent novel therapeutic targets.

Identifiants

pubmed: 33763056
doi: 10.3389/fimmu.2020.629726
pmc: PMC7982406
doi:

Substances chimiques

F2RL1 protein, human 0
Receptor, PAR-2 0
Tryptases EC 3.4.21.59

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

629726

Subventions

Organisme : CIHR
ID : PJT 148565
Pays : Canada

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Abji, Rasti, Gómez-Aristizábal, Muytjens, Saifeddine, Mihara, Motahhari, Gandhi, Viswanathan, Hollenberg, Oikonomopoulou and Chandran.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
Biochem J. 2003 Aug 15;374(Pt 1):97-107
pubmed: 12795636
Arthritis Res Ther. 2017 Sep 21;19(1):210
pubmed: 28934972
J Biomed Sci. 2017 Nov 15;24(1):85
pubmed: 29141644
Nat Rev Rheumatol. 2016 Aug;12(8):472-85
pubmed: 27383913
Arthritis Rheum. 2011 Feb;63(2):382-90
pubmed: 21279995
Mol Pharmacol. 2017 Nov;92(5):519-532
pubmed: 28842394
J Inflamm Res. 2016 Feb 09;9:1-11
pubmed: 26929657
Curr Opin Rheumatol. 2012 Jul;24(4):351-8
pubmed: 22488076
Infect Immun. 1999 Nov;67(11):5573-8
pubmed: 10531202
Biol Chem. 2012 Apr;393(5):421-7
pubmed: 22505524
Microsc Res Tech. 2003 Aug 15;61(6):504-13
pubmed: 12879418
PLoS One. 2013 Apr 18;8(4):e61923
pubmed: 23637930
Clin Exp Allergy. 2017 Jul;47(7):946-960
pubmed: 28317204
Bioorg Med Chem Lett. 2006 Jun 1;16(11):2882-5
pubmed: 16554154
Nucleic Acids Res. 2014 Jan;42(Database issue):D503-9
pubmed: 24157837
Ann Rheum Dis. 2012 Sep;71(9):1559-66
pubmed: 22563031
Rheumatol Int. 2012 Oct;32(10):3077-86
pubmed: 21913036
J Rheumatol. 2011 May;38(5):911-20
pubmed: 21285164
Respir Res. 2019 Jan 18;20(1):14
pubmed: 30658649
Mol Carcinog. 2014 Aug;53(8):659-66
pubmed: 23475608
J Pharmacol Exp Ther. 2018 Feb;364(2):246-257
pubmed: 29263243
J Proteomics. 2013 Aug 2;88:92-103
pubmed: 23501838
Ann Allergy Asthma Immunol. 2019 Mar;122(3):318-330.e3
pubmed: 30508584
Arthritis Rheum. 2007 Mar;56(3):765-71
pubmed: 17328048
Ann Rheum Dis. 2012 Jun;71(6):1049-54
pubmed: 22294633
Arthritis Rheum. 2002 Sep;46(9):2268-79
pubmed: 12355473
Nat Rev Rheumatol. 2017 Sep;13(9):538-547
pubmed: 28794515
Ann Rheum Dis. 2016 Nov;75(11):1989-1997
pubmed: 26698846
J Clin Invest. 2001 Mar;107(5):631-40
pubmed: 11238564
J Biomed Sci. 2011 Jun 17;18:43
pubmed: 21682866
J Cell Biochem. 2019 Jun;120(6):9799-9809
pubmed: 30552714
J Clin Invest. 2003 Jan;111(1):35-41
pubmed: 12511586
BMC Musculoskelet Disord. 2014 Mar 19;15:93
pubmed: 24641725
Arthritis Rheum. 2012 Jan;64(1):88-98
pubmed: 21905006
Arthritis Rheum. 2005 Apr;52(4):1325-32
pubmed: 15818676
J Biol Chem. 1994 Jul 22;269(29):18843-8
pubmed: 8034638
Sci Rep. 2018 May 18;8(1):7834
pubmed: 29777136
Clin Chem Lab Med. 2013 Feb;51(2):317-25
pubmed: 23096109
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Allergol Int. 2017 Jul;66(3):463-471
pubmed: 28216055
Arthritis Rheum. 2001 Aug;44(8):1744-53
pubmed: 11508424
J Leukoc Biol. 1996 Apr;59(4):555-61
pubmed: 8613704
Nat Rev Rheumatol. 2018 Mar;14(3):170-180
pubmed: 29416136
Proc Natl Acad Sci U S A. 1990 May;87(10):3811-5
pubmed: 2187193
Immunity. 2010 Sep 24;33(3):375-86
pubmed: 20832340
J Biol Chem. 1995 Jun 2;270(22):13483-9
pubmed: 7768952
Arthritis Rheum. 2006 Aug;54(8):2665-73
pubmed: 16871531
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1940-1951
pubmed: 28456643
J Rheumatol. 1991 Dec;18(12):1863-71
pubmed: 1724464
Clin Exp Rheumatol. 1999 Mar-Apr;17(2):161-70
pubmed: 10342041
Nat Rev Rheumatol. 2015 Jul;11(7):415-29
pubmed: 25907700
J Biol Chem. 2006 Oct 27;281(43):32095-112
pubmed: 16885167
Br J Pharmacol. 2014 Mar;171(5):1180-94
pubmed: 24354792
Arthritis Res Ther. 2007;9(6):R121
pubmed: 18031579
J Thromb Haemost. 2003 Dec;1(12):2510-5
pubmed: 14675085
J Pharmacol Exp Ther. 2006 Mar;316(3):1017-24
pubmed: 16260582
Inflamm Res. 2009 Mar;58(3):119-26
pubmed: 19184346
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Arthritis Rheum. 2007 Jan;56(1):101-7
pubmed: 17195212
Ann Rheum Dis. 2010 Nov;69(11):2051-4
pubmed: 20584806
Best Pract Res Clin Rheumatol. 2001 Dec;15(5):805-29
pubmed: 11812023
Innate Immun. 2012 Apr;18(2):193-203
pubmed: 21239455
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13936-41
pubmed: 11717450
Arthritis Rheum. 2009 Mar;60(3):728-37
pubmed: 19248120
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
Clin Proteomics. 2014 Jul 01;11(1):27
pubmed: 25097465
Nat Protoc. 2006;1(6):2856-60
pubmed: 17406544
J Biol Chem. 1999 Oct 22;274(43):30784-93
pubmed: 10521469
Arthritis Rheumatol. 2014 Dec;66(12):3337-48
pubmed: 25200274
J Pharmacol Exp Ther. 2008 Aug;326(2):453-62
pubmed: 18477767
Curr Opin Rheumatol. 2007 May;19(3):289-95
pubmed: 17414958
Ann Rheum Dis. 2013 Jul;72(7):1149-55
pubmed: 22941767
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Pharmacol Rev. 2016 Oct;68(4):1110-1142
pubmed: 27677721
J Pathol. 2002 Mar;196(3):343-50
pubmed: 11857499
Pharmacol Ther. 2011 Jun;130(3):248-82
pubmed: 21277892
Blood. 2003 Oct 1;102(7):2645-52
pubmed: 12805069
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Innate Immun. 2013 Dec;19(6):663-72
pubmed: 23606513
Anaesthesia. 2004 Jul;59(7):695-703
pubmed: 15200544
Clin Diagn Lab Immunol. 2000 Nov;7(6):920-4
pubmed: 11063499
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
J Biol Chem. 2013 Feb 22;288(8):5790-802
pubmed: 23288842
Arthritis Rheum. 2010 Jan;62(1):22-32
pubmed: 20039405
J Biol Chem. 2008 Feb 8;283(6):3031-3041
pubmed: 18056261
Cytometry A. 2012 Oct;81(10):823-34
pubmed: 22837127
Cytokine. 2000 Sep;12(9):1312-21
pubmed: 10975989
Clin Rev Allergy Immunol. 2018 Dec;55(3):379-390
pubmed: 30109481

Auteurs

Fatima Abji (F)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Mozhgan Rasti (M)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Alejandro Gómez-Aristizábal (A)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Carla Muytjens (C)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Mahmoud Saifeddine (M)

Department of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.

Koichiro Mihara (K)

Department of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.

Majid Motahhari (M)

Department of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.

Rajiv Gandhi (R)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Division of Orthopaedic Surgery, Department of Surgery, Toronto Western Hospital, Toronto, ON, Canada.

Sowmya Viswanathan (S)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Morley D Hollenberg (MD)

Department of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.

Katerina Oikonomopoulou (K)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Vinod Chandran (V)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Department of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH